ImaginAb completes $12.8 million financing to accelerate growth plans

LOS ANGELES: LOS ANGELES, June 3, 2021 /PRNewswire/ -- ImaginAb Inc, a leading biotechnology company focused on developing next generation radiopharmaceutical imaging and therapy agents, has secured an additional $12.8 million in growth capital. The financing was led by existing investors Adage Capital and Cycad Group and includes new investors...

Click to view original post